CDC panel debates Pfizer COVID-19 vaccine for children
The agency must sign off after the Food and Drug Administration last week authorized the doses for ages 5 to 11.
More from Kennebec & Moose River Valleys
Kennebec Journal | Augusta
High school Alpine ski preview: Mt. Blue hopes to rule the slopes again
Kennebec & Moose River Valleys
•
Dec 5, 2022
Kennebec Journal | Augusta
U.S. offshore wind power gets jump-start with 1st lease auction
Kennebec & Moose River Valleys
•
Dec 5, 2022
Kennebec Journal | Augusta
2022-23 central Maine high school sports winter season previews
Kennebec & Moose River Valleys
•
Dec 5, 2022
Kennebec Journal | Augusta
Police use of weaponized robots in San Francisco renews debate over their use
Kennebec & Moose River Valleys
•
Dec 5, 2022
Kennebec Journal | Augusta
Connecticut hemp farmers want to be given preference for growing recreational marijuana
Kennebec & Moose River Valleys
•
Dec 5, 2022
Kennebec Journal | Augusta
Gov. Mills announces changes in communications office
Kennebec & Moose River Valleys
•
Dec 5, 2022
Kennebec Journal | Augusta
Judge denies legislators access to child protection files
Kennebec & Moose River Valleys
•
Dec 5, 2022
Kennebec Journal | Augusta
World Cup roundup: Croatia beats Japan in shootout to reach quarterfinals
Kennebec & Moose River Valleys
•
Dec 5, 2022